Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.471 USD | +5.81% | -0.63% | -17.92% |
May. 10 | Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010. | CI |
May. 07 | Transcript : Cumberland Pharmaceuticals Inc., Q1 2024 Earnings Call, May 07, 2024 |
Business Summary
Number of employees: 91
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Pharmaceutical Products
100.0
%
| 42 | 100.0 % | 40 | 100.0 % | -5.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.2
%
| 41 | 96.4 % | 38 | 97.2 % | -5.08% |
Non-United States
2.8
%
| 2 | 3.6 % | 1 | 2.8 % | -26.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
John Hamm
DFI | Director of Finance/CFO | 67 | 18-12-31 |
James Herman
CMP | Compliance Officer | 67 | 02-12-31 |
Director/Board Member | 72 | 99-01-05 | |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
Chris Bitterman
SAM | Sales & Marketing | 58 | 17-12-31 |
Kenny Acevedo
SAM | Sales & Marketing | - | 10-12-31 |
Adam Mostafa
PRN | Corporate Officer/Principal | 44 | 16-12-31 |
Tan Cheow Choon
PRN | Corporate Officer/Principal | - | - |
Todd Anthony
PRN | Corporate Officer/Principal | - | 09-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Brown
BRD | Director/Board Member | 59 | 22-07-14 |
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
Ken Krogulski
BRD | Director/Board Member | 66 | 17-01-17 |
Joseph Galante
BRD | Director/Board Member | 74 | 18-09-18 |
Director/Board Member | 72 | 99-01-05 | |
James Jones
BRD | Director/Board Member | 76 | 09-12-31 |
Caroline Young
BRD | Director/Board Member | 49 | 16-06-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,191,229 | 7,945,247 ( 55.99 %) | 0 | 55.99 % |
Company contact information
Cumberland Pharmaceuticals, Inc.
1600 West End Avenue Suite 1300
37203, Nashville
+
http://www.cumberlandpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-17.92% | 19.73M | |
+20.14% | 43.3B | |
+23.67% | 22.22B | |
+16.89% | 15.43B | |
+23.10% | 14.48B | |
+57.58% | 12.72B | |
-0.05% | 6.79B | |
-10.69% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- CPIX Stock
- Company Cumberland Pharmaceuticals Inc.